Novel 6,5-Bicyclic Compounds as 5-HT2A Receptor Agonists for Treating Depression, Anxiety, Substance Abuse, and Headaches

The document describes novel 6,5-bicyclic compounds that act as agonists of the 5-HT2A receptor. It covers pharmaceutical compositions containing these compounds, their potential use in treating depression, anxiety, substance abuse, and headaches, and processes for synthesizing them. This is a patent or chemical disclosure focused on drug discovery and pharmacology, not an empirical study with results.

Study at a glance

Abstract

High Resolution Image Download MS PowerPoint Slide Provided herein are novel 6,5-bicyclic compounds as 5-HT2A receptor agonists, pharmaceutical compositions, use of such compounds in treating depression, anxiety, substance abuse, and headaches, and processes for preparing such compounds.